These advancements hold promise for transforming how we take these medications, moving from needles to pills
Second, pharmacokinetic sub-studies embedded within clinical trials should confirm systemic exposure at the population level, enabling post hoc correlation of plasma curcumin concentrations with clinical response a design feature that would substantially improve the mechanistic interpretability of outcomes
Jade Esmeralda, MS, CSCS, is a Staff Writer, Health & Fitness
GLP-1 Receptor Agonist Therapy carries potential risks and side effects including nausea (30-40%), vomiting, gastrointestinal distress, diarrhea, dizziness, and headaches
For some people, GLP-1 medications may reduce food noise, decrease distress around eating, or feel supportive in ways they didn't anticipate